Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032.
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Scott Joseph Antonia, Johanna C. Bendell, Matthew Hiram Taylor, Emiliano Calvo, Dirk Jaeger, Filippo G. De Braud, Patrick Alexander Ott, M. Catherine Pietanza, Leora Horn, Dung T. Le, Michael Morse, Jose A. Lopez-Martin, Paolo Antonio Ascierto, Olaf Christensen, Joseph Grosso, Jason S. Simon, Chen-Sheng Lin, Joseph Paul Eder
Institutions: Moffitt Cancer Center, Sarah Cannon, Oregon Health & Science University, University Hospital Heidelberg, National Center for Tumor Diseases, Fondazione IRCCS Istituto Nazionale dei Tumori, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Duke Medical Center, Hospital Universitario 12 De Octubre, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Bristol-Myers Squibb (United States), Yale Cancer Center
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2341288331